Insulet Corp (PODD)
235.61
+4.08
(+1.76%)
USD |
NASDAQ |
Nov 01, 16:00
235.71
+0.10
(+0.04%)
After-Hours: 20:00
Insulet Shareholders Equity (Quarterly): 998.40M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 998.40M |
March 31, 2024 | 790.70M |
December 31, 2023 | 732.70M |
September 30, 2023 | 607.50M |
June 30, 2023 | 553.90M |
March 31, 2023 | 502.80M |
December 31, 2022 | 476.40M |
September 30, 2022 | 428.00M |
June 30, 2022 | 422.40M |
March 31, 2022 | 446.70M |
December 31, 2021 | 556.30M |
September 30, 2021 | 497.90M |
June 30, 2021 | 459.10M |
March 31, 2021 | 585.30M |
December 31, 2020 | 603.60M |
September 30, 2020 | 595.00M |
June 30, 2020 | 563.30M |
March 31, 2020 | 59.00M |
December 31, 2019 | 75.90M |
September 30, 2019 | 150.57M |
June 30, 2019 | 249.78M |
March 31, 2019 | 223.63M |
December 31, 2018 | 212.10M |
September 30, 2018 | 197.93M |
June 30, 2018 | 179.15M |
Date | Value |
---|---|
March 31, 2018 | 170.57M |
December 31, 2017 | 158.52M |
September 30, 2017 | 74.25M |
June 30, 2017 | 64.72M |
March 31, 2017 | 63.58M |
December 31, 2016 | 63.15M |
September 30, 2016 | 65.10M |
June 30, 2016 | 27.44M |
March 31, 2016 | 26.40M |
December 31, 2015 | 34.05M |
September 30, 2015 | 55.13M |
June 30, 2015 | 70.26M |
March 31, 2015 | 80.74M |
December 31, 2014 | 83.83M |
September 30, 2014 | 80.34M |
June 30, 2014 | 77.88M |
March 31, 2014 | 122.49M |
December 31, 2013 | 124.60M |
September 30, 2013 | 121.43M |
June 30, 2013 | 138.34M |
March 31, 2013 | 129.55M |
December 31, 2012 | 44.18M |
September 30, 2012 | 39.11M |
June 30, 2012 | 47.75M |
March 31, 2012 | 58.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
59.00M
Minimum
Mar 2020
998.40M
Maximum
Jun 2024
523.94M
Average
553.90M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
Baxter International Inc | 7.643B |
Boston Scientific Corp | 20.37B |
Abbott Laboratories | 39.80B |
Globus Medical Inc | 3.976B |
Bioventus Inc | 150.94M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.882B |
Total Liabilities (Quarterly) | 1.883B |
Debt to Equity Ratio | 1.40 |
Current Ratio | 3.598 |
Net Debt Paydown Yield | -0.00% |